Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Clinical trial NCT05680233 · COMPLETED

Trial details

NCT number: NCT05680233
Sponsor: Oasis Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver

Start date: 2023-03-06
Primary completion: 2024-07-02
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.